Female Infertility Epidemiology Analysis and Forecast to 2033
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
Female Infertility Report Overview
In the 7MM, there were 420,793 diagnosed incident cases of female infertility in 2023. The diagnosed incident cases of female infertility will decline at an AGR of less than 1% during 2023-2033. The major causative factors of infertility and impaired fecundity are fallopian tube dysfunction, disorders of menstruation, sexual disorders, increasing age, and in a very small percentage of patients, ovarian failure.
Female Infertility Market Outlook, 2023-2033 (Diagnosed Incident Cases)
Buy the Full Report for More Insights into the Female Infertility Market Forecast
The female infertility market research report provides an overview of the risk factors, comorbidities, and global and historical trends for female infertility in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan). The report also includes a 10-year epidemiological forecast for the diagnosed incident cases of female infertility, total prevalent cases of female infertility, and total prevalent cases of impaired fecundity, segmented by age (ages 15-24 years, 25-34 years, and 35-44 years) in these markets. Additionally, this report provides the total prevalent cases of female infertility by major etiological factors (endometriosis, fallopian tube abnormalities, hormonal/metabolic disorders, ovulatory dysfunction disorders, uterine abnormalities, and unexplained factors).
| Market Size (2023) | 420,793 Cases |
| AGR (2023-2033) | >(1)% |
| Forecast Period | 2023-2033 |
| Key Countries | · The US
· France · Germany · Spain · Italy · The UK · Japan |
| Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Female Infertility Market Segmentation by Country
The key countries across the 7MM are the US, France, Germany, Spain, Italy, the UK, and Japan. In 2023, the US accounted for the highest percentage of diagnosed incident cases of female infertility in the 7MM while Spain will have the highest AGR. Any changes in the total incident cases of female infertility is attributable to changing population demographics in the 7MM. Among the 7MM, the US had the highest number of total prevalent cases of female infertility due to ovulatory function disorders.
Female Infertility Market Analysis by Country, 2023 (%)
Buy the Full Report for More Country Insights into the Female Infertility Market
Download a Free Report Sample
Segments Covered in the Report
Female Infertility Country Outlook (Diagnosed Incident Cases, 2023)
- The US
- France
- Germany
- Spain
- Italy
- The UK
- Japan
Scope
This report provides an overview of the risk factors, comorbidities, and the global and historical epidemiological trends for female infertility in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan). The report includes a 10-year epidemiology forecast for the diagnosed incident cases of female infertility, total prevalent cases of female infertility, and total prevalent cases of impaired fecundity. The diagnosed incident and total prevalent cases of female infertility and total prevalent cases of impaired fecundity are further segmented by age (15–24 years, 25–34 years, and 35–44 years). Additionally, this report provides the total prevalent cases of female infertility by major etiological factors (endometriosis, fallopian tube abnormalities, hormonal/metabolic disorders, ovulatory dysfunction disorders, uterine abnormalities, and unexplained factors). This epidemiology forecast for female infertility is supported by historical data obtained from peer-reviewed articles and population-based studies. GlobalData epidemiologists used the clinical definition of female infertility given by the World Health Organization (WHO) to assess the total prevalence of female infertility across the 7MM. The forecast methodology was kept consistent across the 7MM to allow for a meaningful comparison of the forecast diagnosed incident and total prevalent cases of female infertility across these markets.
Reasons to Buy
The female infertility epidemiology series will allow you to:
- Develop business strategies by understanding the trends shaping and driving the global female infertility market.
- Quantify patient populations in the global female infertility market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups that present the best opportunities for female infertility therapeutics in each of the markets covered.
Table of Contents
Table
Figures
Frequently asked questions
-
How many diagnosed incident cases of female infertility were seen in the 7MM in 2023?
In 2023, there were 420,793 diagnosed incident cases of female infertility in the 7MM.
-
What will the growth rate of the female infertility market be during the forecast period?
The diagnosed incident cases of female infertility will register a negative AGR of less than 1% during 2023-2033.
-
Which country accounted for the highest percentage of diagnosed incident cases of female infertility in the 7MM in 2023?
In 2023, the US accounted for the highest percentage of diagnosed incident cases of female infertility in the 7MM.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more Women Infertility reports

